The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Indeed but it’s all relative. Not long ago it had £100m in cash, now half of that having bought a business on the verge word bankruptcy. Hardly a resounding endorsement of progress.
And let’s not forget, JM talked of £100m organic revenue. We will be absolutely nowhere near that even with the Yourgene merger. How can he just say such to investors and not be accountable?
heart may have sunk but did you expect anything else? we’re likely going to posing revenue somewhat 1/2 of pre covid but with costs many multiples. we’ve got a ceo who not long ago talked about £100m organic revenue and then just rolled back on it unchallenged and sort of laughed it off. you said it, you ******* cretin.
to be fair to him, i can’t see how he fits in now. new cfo and lr will clearly be ceo so perhaps jm’s severance package is being worked up as we speak
Purely anecdotal but I work in a large office which is almost full 3 days a week and have heard nothing about covid, nor in any of my other circles. Seasonal colds but not much else. Covid is effectively done and there is no more money in it for NCYT. Heck, we can't even get the money from 2020 when it was a thing so I doubt we're getting any more now.
Nail on head again CS. As I alluded to earlier, I've personally moved away from looking at it through the lens of my average as that is once in a lifetime, covid skewed. Forget 'averaging down' just because you're in too high, you have to accept that a vast chunk of that money has gone (on paper as it stands now, and there looks to be no impetus for it to improve) and look at it as a new investment in a way by saying 'at 63p do I think NCYT will make me money?'. Unfortunately no II's are touching this, the BoD seemingly aren't interested, we're losing millions a year and have a totally insipid board and as such very few people think that they'll get any return on an investment in NCYT.
CS it's likely valued less than cash due to 2 things - 1. the dispute and 2. anticipation of years of losses as the company looks to be going backwards financially.
CS is spot on in his/her analysis. Good luck if you are waiting for £6 but just think of the scale of rise that is on the current price, an almost 10 fold increase for a company losing millions per year. A marcap of almost half a billion. It's ludicrous. I am very negative about the company but have accepted that my money is largely gone, and I've left the final 10-12% in for a gamble on the dispute. Frankly, what is left isn't worth cashing out given how much it started as. I like you got swept up in the hype and bought in the £8's, was distraught when my average was over £4 and it dropped to £2 etc and then, for some bizarre unknown reason, in Nov 2021 my holding just tipped into a tiny profit and until my dying day I will not be able to find an answer why I didn't press the sell all button to get out of this. Naive investing and greed is the only answer for such mistakes. It took me a long time to get over that utterly dreadful decision. Even typing about it makes me cringe and wonder what on earth I was thinking, but that's life which is a constant learning curve.
Back to NCYT, the whole operation is and always seems to have been a very, very small company and mindset and to suddenly propel that to midcap takes more than that. We are run seemingly by people not capable or interested in growing the company, to be fair on the whole they probably aren't bad people but are just out of their depth. As someone said, we've lost 2 years of progress by not appointing a proper CEO. There is no serious demand for our products, as there wasn't before covid, but the pandemic made some of us think and act irrationally.
HOpefully we avoid defeat in the dispute and even if the cash balance isn't topped up, getting it out of the way may see a 10-20p increase just due the uncertainty being removed. Beyond that, I can't see where the SP growth comes from when we're posting losses every year.
Obviously I am an awful investor so don't take any of this as advice. I'd be over the moon with £1.50 which is a pittance to where we were not so long ago but is more than doubling of the current SP for context. Over 100% rise just to get to £1.50 - when you type and read it out it really hammers home how unlikely it is.
Ultimately it comes down to making money, which is all we and they presumably care about. We've all got bills to pay. They know the inside of the business and clearly think there is no value in buying at these prices, which is incredibly worrying with the dispute resolution to come (do they have no faith we will not lose/come out favourably?)
At any point in the last 17 months? Ok most of that is pre YG merger but board is largely the same tired old faces. It shows absolutely no faith. They’re all businessmen out to make money, if they saw value in the company they’d be buying when the SP is on its knees, but they’re not.
Not a single share purchase by a director since July 2022. Above all else, that is very worrying.
Announced Traded Action Notifier Price Currency Amount Holding
15-Jul-22 11-Jul-22 Transfer To Edwin Snape - - 17,919 17,919
07-Jul-22 07-Jul-22 Buy James Wakefield 117.00 GBX 7,000 43,839
25-Mar-22 25-Mar-22 Buy David Allmond 231.00 GBX 43,500 43,500
18-Mar-22 15-Mar-22 Buy Jean-Pierre Crinelli 2.58 EUR 5,800 45,581
18-Mar-22 18-Mar-22 Buy Jean-Pierre Crinelli 241.00 GBX 3,208 45,581
15-Mar-22 14-Mar-22 Buy James McCarthy 212.00 GBX 2,360 39,670
15-Mar-22 14-Mar-22 Buy James McCarthy 201.00 GBX 37,310 39,670
all that is ‘going on’ is traders trading and making money. yes another **** day but for now at least until tomorrow the week to date is up 18% and month 58%. some sense of respite for what is generally a complete dog of a stock